Care4Sight Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.00 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Net Worth
- Total Assets 77.21%
(FY 2023)
About Care4Sight Pharma
The Corporate was formerly known as Contacare Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹15.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Purnima Dave and Jagrat Dave serve as directors at the Company.
- CIN/LLPIN
U24304MH2019PTC332244
- Company No.
332244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Care4Sight Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Dave  | Director | 25-Oct-2019 | Current |
| Jagrat Dave | Director | 25-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Care4Sight Pharma.
Care4Sight Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Care4Sight Pharma?
In 2023, Care4Sight Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Caregroup Sight Solution Private LimitedActive 4 years 11 monthsPurnima Dave and Jagrat Dave are mutual person
Contacare Opthalmic Private LimitedActive 27 years 7 monthsPurnima Dave and Jagrat Dave are mutual person
- Intra Ocular Care Private LimitedActive 35 years 14 days
Purnima Dave and Jagrat Dave are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Mar 2020 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Care4Sight Pharma?
Unlock and access historical data on people associated with Care4Sight Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Care4Sight Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Care4Sight Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
